ORCID ID
Loury Priskila: 0009-0007-3633-3543
Lenggana Relung Atmadi: 0009-0007-5926-0543
Arya Taksya Bagaskara: 0009-0008-0423-7423
Andreas Mercyan Anggitama: 0009-0005-0560-5732
Abstract
Background: Stroke is the second leading cause of mortality worldwide. In Yogyakarta, Indonesia, the incidence of stroke (14%) is higher than the national average. We therefore investigated the roles of LDLR rs688 (C/T) and PCSK9 rs562565 (A/G) polymorphisms in familial hypercholesterolemia as predictors of first-time ischemic stroke.
Methods: In this case-control study, 119 first-time ischemic stroke patients were divided into dyslipidemia (N = 71) and non-dyslipidemia groups (N = 48). The DNA of the nucleotide polymorphisms LDLR rs688 (C/T) and PCSK9 rs562556 (A/G) was extracted and analyzed using the PCR-RFLP method, and statistical analyses were performed to evaluate their predictive potential.
Results: The LDLR rs688 (C/T) CT genotype was the most common in both groups. The TT genotype appeared slightly more frequently in the dyslipidemia group, but no significant association was found with dyslipidemia (p = 0.460). While lipid levels had no significant relationship with LDLR rs688 (C/T), hemoglobin levels differed significantly across the genotypes (p = 0.002), which suggested the biological relevance of hemoglobin.
Conclusions: The LDLR rs688 (C/T) polymorphism was not significantly associated with dyslipidemia among the stroke patients. Nonetheless, genotype-related trends related to lipid and hemoglobin levels indicated potential mechanisms that warrant further investigation.
References
- Turana Y, Tengkawan J, Chia YC, Nathaniel M, Wang JG, Sukonthasarn A, et al. Hypertension and stroke in Asia: A comprehensive review from HOPE Asia. J Clin Hypertens. 2021;23:513–21.
- Tadi P, Lui F. Acute stroke. Treasure Island (FL): StatPearls Publishing; 2025.
- Donkor ES. Stroke in the 21st century: A snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018;2018:3238165.
- Feigin VL, Vos T. Global burden of neurological disorders: From global burden of disease estimates to actions. Neuroepidemiology. 2019;52:1–2.
- Pu L, Wang L, Zhang R, Zhao T, Jiang Y, Han L. Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030. Stroke. 2023;54:1330–9.
- Baba M, Maris M, Jianu D, Luca CT, Stoian D, Mozos I. The impact of the blood lipids levels on arterial stiffness. J Cardiovasc Dev Dis. 2023;10:127.
- Fekadu G, Chelkeba L, Kebede A. Risk factors, clinical presentations and predictors of stroke among adult patients admitted to stroke unit of Jimma University medical center, South West Ethiopia: Prospective observational study. BMC Neurol. 2019;19:187.
- Sabih QA, Young J, Takabe K. Management of male breast cancer: The journey so far and future directions. World J Oncol. 2021;12:206–13.
- Roy-O’Reilly M, McCullough LD. Age and sex are critical factors in ischemic stroke pathology. Endocrinology. 2018;159:3120–31.
- Yousufuddin M, Young N. Aging and ischemic stroke. Aging. 2019;11:2542–4.
- Jacob MA, Ekker MS, Allach Y, Cai M, Aarnio K, Arauz A, et al. Global differences in risk factors, etiology, and outcome of ischemic stroke in young adults-A worldwide meta-analysis: The GOAL Initiative. Neurology. 2022;98:e573–88.
- Khadka T, Giri GK, Sherpa P, Ghimire U, Parajuli S, Pudasaini A, et al. Dyslipidemia among patients with ischemic stroke admitted to the department of medicine of a tertiary care centre. JNMA J Nepal Med Assoc. 2023;61:718–22.
- Kloska A, Malinowska M, Gabig-Cimińska M, Jakóbkiewicz-Banecka J. Lipids and Lipid mediators associated with the risk and pathology of ischemic stroke. Int J Mol Sci. 2020;21:3618.
- Feingold KR. Introduction to lipids and lipoproteins. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2024.
- Pirahanchi Y, Sinawe H, Dimri M. Biochemistry, LDL cholesterol. Treasure Island (FL): StatPearls Publishing; 2025.
- Yang H-x, Zhang M, Long S-y, Tuo Q-h, Tian Y, Chen J-x, et al. Cholesterol in LDL receptor recycling and degradation. Clinica Chimica Acta. 2020;500:81–6.
- Hasheminasabgorji E, Jha JC. Dyslipidemia, diabetes and atherosclerosis: Role of inflammation and ros-redox-sensitive factors. Biomedicines. 2021;9:1602.
- Dai Z, Wang Y, Li P, Zhang H, Gou X. The association between polymorphism of LDL-R gene and ischemic stroke risk in Chinese population: A meta-analysis. Heliyon. 2024;10:e26314.
- Ferreira JP, Xhaard C, Lamiral Z, Borges‐Canha M, Neves JS, Dandine‐Roulland C, et al. PCSK9 Protein and rs562556 Polymorphism Are associated with arterial plaques in healthy middle‐aged population: The STANISLAS Cohort. J Am Heart Assoc. 2020;9:e014758.
- Hashim HO, Al-Shuhaib MB. Exploring the potential and limitations of PCR-RFLP and PCR-SSCP for SNP detection: A review. J Apple Biotechnol Rep. 2019;6:137–44.
- Muneeswaran K, De Silva VA, Branavan U, Dayabandara M, Hanwella R, Chandrasekharan NV. PCR-based SNP genotyping: A comprehensive comparison of methods for affordable and accurate detection of class IV mutations. Analytica Chimica Acta. 2025;1354:343994.
- Kim Y, Choi SJ, Choi C. An efficient PCR-RFLP Method for the rapid identification of Korean Pyropia species. Molecules. 2017;22:2182.
- Buraczynska M, Jacob J, Gwiazda-Tyndel K, Ksiazek A. LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients. BMC Nephrol. 2021;22:316.
- Devi K, Bhargave A, Ahmad I, Yadav A, Gupta R. Association study of PCSK9 SNPs (rs505151 & rs562556) and their haplotypes with CVDs in Indian population. Ann Hum Biol. 2023;50:56–62.
- Eren K, Taktakoğlu N, Pirim I. DNA sequencing methods: From past to present. Eurasian J Med. 2022;54:47–56.
- Desai A, Oh D, Rao EM, Sahoo S, Mahajan UV, Labak CM, et al. Impact of anemia on acute ischemic stroke outcomes: A systematic review of the literature. Thanachartwet V, editor. PLoS One. 2023;18:e0280025.
- Al-Harbi N, Alrasheedi MS, Alshammari ST. Hemoglobin level is associated with severe stroke among stroke patients in Saudi Arabia. Int J Health Sci. 2020;14:18–22.
- Barlas RS, Honney K, Loke YK, McCall SJ, Bettencourt‐Silva JH, Clark AB, et al. Impact of hemoglobin levels and anemia on mortality in acute stroke: Analysis of UK Regional registry data, systematic review, and meta‐analysis. J Am Heart Assoc. 2016;5:e003019.
- Kellert L, Martin E, Sykora M, Bauer H, Gussmann P, Diedler J, et al. Cerebral oxygen transport failure?: Decreasing hemoglobin and hematocrit levels after ischemic stroke predict poor outcome and mortality: STroke: RelevAnt Impact of hemoGlobin, Hematocrit and Transfusion (STRAIGHT)—an Observational Study. Stroke. 2011;42:2832–7.
- Zhang R, Xu Q, Wang A, Jiang Y, Meng X, Zhou M, et al. Hemoglobin concentration and clinical outcomes after acute ischemic stroke or transient ischemic attack. J Am Heart Assoc. 2021;10:e022547.
- Tanne D, Molshatzki N, Merzeliak O, Tsabari R, Toashi M, Schwammenthal Y. Anemia status, hemoglobin concentration and outcome after acute stroke: A cohort study. BMC Neurol. 2010;10:22.
- Abuhulayqah S, Aldulijan FA, Turkistani AN, Almulhim AF, Almulhim CF, Bashir S, et al. Impact of hemoglobin levels on acute ischemic stroke severity. Front Neurol. 2025;16:1534746.
- Andone S, Farczádi L, Imre S, Bălașa R. Fatty acids and lipid paradox-neuroprotective biomarkers in ischemic stroke. Int J Mol Sci. 2022;23:10810.
Recommended Citation
Priskila L, Atmadi L, Bagaskara A, Anggitama A. Current Insight into LDLR and PCSK9 Genetic Variants: Investigating Genetic Keys to Cholesterol in a Cohort of Stroke Patients from Yogyakarta, Indonesia. Makara J Health Res. 2025;29.
Creative Commons License

This work is licensed under a Creative Commons Attribution-Share Alike 4.0 International License.
